Inadequate antimicrobial prophylaxis during surgery: A study of β-lactam levels during burn debridement

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 1, 2007, Pages 166-169

  Dalley, Andrew J ^a   Lipman, Jeffrey ^a,b   Venkatesh, Bala ^c   Rudd, Michael ^b   Roberts, Michael S ^a   Cross, Sheree E ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Adult burns; Antibiotic prophylaxis; Drug administration schedule; Intraoperative period

Indexed keywords

CEFALOTIN; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BURN; CLINICAL ARTICLE; CONTROLLED STUDY; DEBRIDEMENT; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HIGH RISK PATIENT; HUMAN; INFECTION RISK; MALE; MINIMUM INHIBITORY CONCENTRATION; PEROPERATIVE CARE; PSEUDOMONAS AERUGINOSA; RECOMMENDED DRUG DOSE; RISK REDUCTION; SKIN TRANSPLANTATION; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; BETA-LACTAMS; BURNS; CEPHALOTHIN; DEBRIDEMENT; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; PENICILLANIC ACID; PIPERACILLIN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 34447562711     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm128     Document Type: Article

References (11)

1. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: An advisory statement from the National Surgical Infection Prevention Project. Am J Surg 2005; 189: 395-404.
2. Victorian Drug Usage Advisory Committee. Therapeutic Guidelines - Thirteenth Edition: Antibiotic. Melbourne, Australia: VMPF Therapeutics Committee, 2006.
3. Scottish Intercollegiate Guidelines Network. SIGN publication Number 45: Antibiotic Prophylaxis in Surgery. Edinburgh, UK: SIGN Council, 2000.
4. Mozingo DW, McManus AT, Kim SH et al. Incidence of bacteremia after burn wound manipulation in the early postburn period. J Trauma 1997; 42: 1006-10.
5. Sasaki TM, Welch GW, Herndon DN et al. Burn wound manipulation-induced bacteremia. J Trauma 1979; 19: 46-8.
6. Fry DE. The surgical infection prevention project: Processes, outcomes, and future impact. Surg Infect 2006; 7 Suppl 3: S17-s26.
7. Williams JD, Moosdeen F. In vitro antibacterial effects of cephalosporins. Drugs 1987; 34: 44-63.
8. Bryson HM, Brogden RN. Piperacillin/tazobactam - a review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs 1994; 47: 506-35.
9. Zanetti G, Giardina R, Platt R. Intraoperative redosing of cefazolin and risk for surgical site infection in cardiac surgery. Emerg Infect Dis 2001; 7: 828-31.
10. Zelenitsky SA, Ariano RE, Harding GKM et al. Antibiotic pharmacodynamics in surgical prophylaxis: An association between intraoperative antibiotic concentrations and efficacy. Antimicrob Agents Chemother 2002; 46: 3026-30.
11. Roberts J, Lipman J. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis. Clin Pharmacokinet 2006; 45: 755-73.